REFERENCES1.
Hook EW: Trichomonas vaginalis - no longer a minor STD. Sex Transm Dis 1999; 26:388-389.2.
Anosike JC, Onwuliri D, Inyang RE, et al: Trichomoniasis amongst students of a higher institution in Nigeria. Appl Parasitol 1993; 34:19-25.3.
Ogbonna CI, Ogbonna IB, Ogbonna AA, et al: Studies on the incidence of Trichonomas vaginalis amongst pregnant women in Jos area of Plateau State, Nigeria. Angew Parasitol 1991; 32:198-204.4.
Konje JC, Otolorin ED, Ogunniyi JD, et al: The prevalence of Gardnerella vaginalis, Trichomonas vaginalis and Candida albicans in the cytology clinic at Ibadan, Nigeria. Afr J Med Sci 1991; 20:29-34.5.
Yereli K, Balcioglu IC, Degerli K, et al: Incidence of Trichomonas vaginalis among women having vaginal discharge, in Manisa, Turkey. J Egypt Soc Parasitol 1997; 27:905-911.6.
Klinger EV, Kapiga SH, Sam NE, et al: A community-based study of risk factors for Trichomonas vaginalis infection among women and their male partners in Moshi urban district, northern Tanzania. Sex Transm Dis 2006; 33:712-718.7.
Shobeiri F, Nazari M: A prospective study of genital infections in Hamedan, Iran. Southeast Asian J Trop Med Publ Hlth 2006; 37(suppl 3):174-177.8.
Ryu JS, Min DY: Trichomonas vaginalis and trichomoniasis in the Republic of Korea. Korean J Parasitol 2006; 44:101-116.9.
Adu-Sarkodie Y, Opoku BK, Crucitti T, et al: Lack of evidence for the involvement of rectal and oral trichomonads in the aetiology of vaginal trichomoniasis in Ghana. Sex Transm Dis 2007; 83:130-132.10.
Jackson DJ, Rakwar JP, Bwayo JJ, et al: Urethral Trichomonas vaginalis infection and HIV-1 transmission. Lancet 1997; 350:1076.11.
Press N, Chavez VM, Ticona E, et al: Screening for sexually transmitted diseases in human immunodeficiency virus-positive patients in Peru reveals an absence of Chlamydia trachomatis and identifies Trichomonas vaginalis in pharyngeal specimens. Clin Infect Dis 2001; 32:808-814.12.
Niccolai LM, Kopicko JJ, Kassie A, et al: Incidence and predictors of reinfection with Trichomonas vaginalis in HIV-infected women. Sex Transm Dis 2000; 27:284-288.13.
Price MA, Stewart SR, Miller WC, et al: The cost-effectiveness of treating male trichomoniasis to avert HIV transmission in men seeking sexually transmitted disease care in Malawi. J Acquir Immune Defic Syndr 2006; 43:202-209.14.
Råssjö EB, Mirembe FM, Darj E: Vulnerability and risk factors for sexually transmitted infections and HIV among adolescents in Kampala, Uganda. AIDS Care 2006; 18:710-716.15.
Hagan JE, Dulmaa N: Risk factors and prevalence of HIV and sexually transmitted infections among low-income female commercial sex workers in Mongolia. Sex Transm Dis 2007; 34:83-87.16.
McClelland RS, Sangare L, Hassan WM, et al: Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis 2007; 195:698-702.17.
ter Meulen J, Mgaya HN, Chang-Claude J, et al: Risk factors for HIV infection in gynaecological inpatients in Dar es Salaam, Tanzania, 1988-1990. East Afr Med J 1992; 69:688-692.18.
Nwosu CO, Djieyep NA: Candidiasis and trichomoniasis among pregnant women in a rural community in the semi-arid zone, north-eastern Nigeria. West Afr J Med 2007; 26:17-19.19.
Kent HL: Epidemiology of vaginitis. Am J Obstet Gynecol 1991; 165:1168-1176.20.
Sobel JD: Vulvovaginitis. Dermatol Clin 1992; 10:339-359.21.
Hatch KD: Vulvar and vaginal disorders. Curr Opin Obstet Gynecol 1992; 4:904-906.22.
Heine P, McGregor JA: Trichomonas vaginalis: a reemerging pathogen. Clin Obstet Gynecol 1993; 36:137-144.23.
el-Sharkawy IM, Hamza SM, el-Sayed MK: Correlation between Trichomonas vaginalis and female infertility. J Egypt Soc Parasitol 2000; 30:287-294.24.
Fowler Jr JE: Urethritis in men. Semin Urol 1991; 9:15-27.25.
Saxena SB, Jenkins RR: Prevalence of Trichomonas vaginalis in men at high risk for sexually transmitted diseases. Sex Transm Dis 1991; 18:138-142.26.
Krieger JN, Jenny C, Verdon M, et al: Clinical manifestations of trichomoniasis in men. Ann Intern Med 1993; 118:844-849.27.
Krieger JN, Verdon M, Siegel N, et al: Natural history of urogenital trichomoniasis in men. J Urol 1993; 149:1455-1458.28.
Bakare RA, Ashiru JO, Adeyemi-Doro FA, et al: Non-gonococcal urethritis (NGU) due to Trichomonas vaginalis in Ibadan. West Afr J Med 1999; 18:64-68.29.
el-Seoud SF, Abbas MM, Habib FS: Study of trichomoniasis among Egyptian male patients. J Egypt Soc Parasitol 1998; 28:263-270.30.
Levine GI: Sexually transmitted parasitic diseases. Prim Care 1991; 18:101-128.31.
Majeroni BA: New concepts in bacterial vaginosis. Am Fam Physician 1991; 44:1215-1218.32.
Hart G: Factors associated with trichomoniasis, candidiasis and bacterial vaginosis. Int J STD AIDS 1993; 4:21-25.33.
Lossick JG, Kent HL: Trichomoniasis: trends in diagnosis and management. Am J Obstet Gynecol 1991; 165:1217-1222.34.
Weinberger MW, Harger JH: Accuracy of the Papanicolaou smear in the diagnosis of asymptomatic infection with Trichomonas vaginalis. Obstet Gynecol 1993; 82:425-429.35.
Krieger JN, Verdon M, Siegel N, et al: Risk assessment and laboratory diagnosis of trichomoniasis in men. J Infect Dis 1992; 166:1362-1366.36.
Boeke AJ, Dekker JH, Peerbooms PG: A comparison of yield from cervix versus vagina for culturing Candida albicans and Trichomonas vaginalis. Genitourin Med 1993; 69:41-43.37.
Sharma P, Malla N, Gupta I, et al: A comparison of wet mount, culture and enzyme linked immunosorbent assay for the diagnosis of trichomoniasis in women. Trop Geogr Med 1991; 43:257-260.38.
Rubino S, Muresu R, Rappelli P, et al: Molecular probe for identification of Trichomonas vaginalis DNA. J Clin Microbiol 1991; 29:702-706.39.
Riley DE, Roberts MC, Takayama T, et al: Development of polymerase chain reaction-based diagnosis of Trichomonas vaginalis. J Clin Microbiol 1992; 30:465-472.40.
Romia SA, Othman TA: Detection of antitrichomonal antibodies in sera and cervical secretions in trichomoniasis. J Egypt Soc Parasitol 1991; 21:373-381.41.
Bhatt R, Pandit D, Deadhar L: Detection of serum antitrichomonal antibodies in urogenital trichomoniasis by immunofluorescence. J Postgrad Med 1992; 38:72-74.42.
Okuyama T, Takahashi R, Mori M, et al: Polymerase chain reaction amplification of Trichomonas vaginalis DNA from Papanicolaou-stained smears. Diagn Cytopathol 1998; 19:437-440.43.
Madico G, Quinn TC, Rompalo A, et al: Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples. J Clin Microbiol 1998; 36:3205-3210.44.
van Der Schee C, van Belkum A, Zwijgers L, et al: Improved diagnosis of Trichomonas vaginalis infection by PCR using vaginal swabs and urine specimens compared to diagnosis by wet mount microscopy, culture, and fluorescent staining. J Clin Microbiol 1999; 37:4127-4130.45.
Ryu JS, Chung HL, Min DY, et al: Diagnosis of trichomoniasis by polymerase chain reaction. Yonsei Med J 1999; 40:56-60.46.
Mayta H, Gilman RH, Calderon MM, et al: 18S ribosomal DNA-based PCR for diagnosis of Trichomonas vaginalis. J Clin Microbiol 2000; 38:2683-2687.47.
Chunge CN, Kangethe S, Pamba HD, et al: Treatment of symptomatic trichomoniasis among adult women using oral nitroimidazoles. East Afr Med J 1992; 69:398-401.48.
Mahdi NK, Gany ZH, Sharief M: Alternative drugs against Trichomonas vaginalis. East Mediterr Health J 2006; 12:679-684.49.
Sobel JD, Nagappan V, Nyirjesy P: Metronidazole-resistant vaginal trichomoniasis - an emerging problem. N Engl J Med 1999; 341:292-293.50.
Snipes LJ, Gamard PM, Narcisi EM, et al: Molecular epidemiology of metronidazole resistance in a population of Trichomonas vaginalis clinical isolates. J Clin Microbiol 2000; 38:3004-3009.51.
Hager WD, Rapp RP: Metronizadole. Obstet Gynecol Clin North Am 1992; 19:497-510.52.
Anonymous : Drug-resistant Trichomonas vaginalis. Commun Dis Rep CDR Weekly 1993; 3:141.53.
Ikeh EI, Bello CS, Ajayi JA: In vitro susceptibility of Trichomonas vaginalis strains to metronizadole - a Nigerian experience. Genitourin Med 1993; 69:241-242.54.
Hamed KA, Studemeister AE: Successful response of metronizadole-resistant trichomonal vaginitis to tinidazole. A case report. Sex Transm Dis 1992; 19:339-340.55.
O-Prasertsawat P, Jetsawangsri T: Split-dose metronizadole or single-dose tinidazole for the treatment of vaginal trichomoniasis. Sex Transm Dis 1992; 19:295-297.56.
Livengod CH, Lossick JG: Resolution of resistant vaginal trichomoniasis associated with the use of intravaginal nonoxynol-9. Obstet Gynecol 1991; 78:954-956.57.
McCutchan JA, Ronald AR, Corey L, et al: Evaluation of new anti-infective drugs for the treatment of vaginal infections. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 1992; 15(suppl 1):S115-S122.58.
Romoren M, Velauthapillai M, Rahman M, et al: Trichomoniasis and bacterial vaginosis in pregnancy: inadequately managed with the syndromic approach. Bull World Health Organ 2007; 85:297-304.
